Treatment of Antipsychotic-Related Akathisia Revisited: The Role of Serotonin 2A Receptor Antagonists.

Poyurovsky, Michael; Weizman, Abraham

Poyurovsky, Michael; Weizman, Abraham.

Afiliación

Poyurovsky M; From the *Tirat Carmel Mental Health Center affiliated to Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa; and Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

J Clin Psychopharmacol ; 35(6): 711-4, 2015 Dec.

Article en En | MEDLINE | ID: mdl-26488676

ABSTRACT

ABSTRACT

Akathisia remains a prevalent, clinically significant, and therapeutically challenging adverse event associated with antipsychotic treatment. Compelling evidence supports therapeutic efficacy and clinical utility of agents with marked serotonin 2A receptor antagonism, primarily low-dose mirtazapine, as an effective and well-tolerated antiakathisia treatment.

Asunto(s)

Acatisia Inducida por Medicamentos/tratamiento farmacológico; Acatisia Inducida por Medicamentos/etiología; Antipsicóticos/efectos adversos; Antagonistas del Receptor de Serotonina 5-HT2/farmacología; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antipsicóticos / Acatisia Inducida por Medicamentos / Antagonistas del Receptor de Serotonina 5-HT2 Límite: Humans Idioma: En Revista: J Clin Psychopharmacol Año: 2015 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google